Capital International Investors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Capital International Investors’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-967,357	Closed	-$44.6M	–	449
2023 Q2	$44.6M	Sell	967,357 -327,203	-25%	-$15.1M	0.01%	342
2023 Q1	$51.9M	Hold	1,294,560	–	–	0.01%	333
2022 Q4	$60M	Sell	1,294,560 -2,096,522	-62%	-$97.1M	0.02%	318
2022 Q3	$140M	Sell	3,391,082 -21,324	-0.6%	-$883K	0.04%	263
2022 Q2	$204M	Buy	3,412,406 +67,380	+2%	+$4.02M	0.06%	244
2022 Q1	$243M	Sell	3,345,026 -2,024,748	-38%	-$147M	0.06%	242
2021 Q4	$452M	Sell	5,369,774 -295,419	-5%	-$24.8M	0.1%	186
2021 Q3	$511M	Buy	5,665,193 +208,069	+4%	+$18.8M	0.12%	168
2021 Q2	$520M	Buy	5,457,124 +33,002	+0.6%	+$3.15M	0.12%	168
2021 Q1	$618M	Sell	5,424,122 -837,184	-13%	-$95.3M	0.16%	140
2020 Q4	$867M	Buy	6,261,306 +63,357	+1%	+$8.77M	0.24%	114
2020 Q3	$509M	Buy	6,197,949 +112,817	+2%	+$9.27M	0.16%	134
2020 Q2	$476M	Sell	6,085,132 -47,062	-0.8%	-$3.68M	0.16%	131
2020 Q1	$272M	Buy	6,132,194 +89,619	+1%	+$3.98M	0.11%	148
2019 Q4	$258M	Buy	6,042,575 +33,818	+0.6%	+$1.44M	0.09%	168
2019 Q3	$257M	Buy	6,008,757 +390,195	+7%	+$16.7M	0.1%	165
2019 Q2	$357M	Buy	5,618,562 +50,013	+0.9%	+$3.18M	0.14%	148
2019 Q1	$386M	Buy	5,568,549 +978,695	+21%	+$67.9M	0.17%	138
2018 Q4	$200M	Buy	4,589,854 +229,963	+5%	+$10M	0.1%	167
2018 Q3	$333M	Buy	4,359,891 +755,127	+21%	+$57.6M	0.15%	150
2018 Q2	$277M	Buy	3,604,764 +13,718	+0.4%	+$1.05M	0.31%	105
2018 Q1	$183M	Buy	3,591,046 +12,259	+0.3%	+$625K	0.21%	121
2017 Q4	$166M	Buy	3,578,787 +683,306	+24%	+$31.7M	0.19%	127
2017 Q3	$154M	Buy	2,895,481 +520,496	+22%	+$27.7M	0.18%	137
2017 Q2	$148M	Buy	2,374,985 +198,252	+9%	+$12.3M	0.2%	133
2017 Q1	$148M	Buy	2,176,733 +1,175,879	+117%	+$79.7M	0.2%	131
2016 Q4	$70.4M	Buy	1,000,854 +520,554	+108%	+$36.6M	0.1%	170
2016 Q3	$34.1M	Buy	+480,300	New	+$34.1M	0.05%	215